T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Broadstone Net Lease
BNL
$4.37B
| $8.7M | ﹤0.01% |
486,936
+10,315
| +2% | +$177K |
|
1252
Ally Financial
ALLY
$13.6B
| $8.67M | ﹤0.01% |
221,253
+14,466
| +7% | +$580K |
|
1253
GameStop
GME
$8.4B
| $8.62M | ﹤0.01% |
316,115
+21,875
| +7% | +$519K |
|
1254
Brown-Forman Class B
BF.B
$13B
| $8.6M | ﹤0.01% |
317,710
-4,292
| -1% | -$124K |
|
1255
Perdoceo Education
PRDO
$1.99B
| $8.52M | ﹤0.01% |
226,079
+42,562
| +23% | +$1.36M |
|
1256
Dianthus Therapeutics
DNTH
$6.42B
| $8.51M | ﹤0.01% |
216,135
+205,443
| +1,921% | +$5.25M |
|
1257
Blue Bird Corp
BLBD
$2.08B
| $8.48M | ﹤0.01% |
147,384
+29,897
| +25% | +$1.56M |
|
1258
Elanco Animal Health
ELAN
$11.8B
| $8.43M | ﹤0.01% |
418,298
+23,100
| +6% | +$387K |
|
1259
iShares MSCI EAFE ETF
EFA
$80.2B
| $8.34M | ﹤0.01% |
+89,300
| New | +$8.12M |
|
|
FOLD
1260
DELISTED
Amicus Therapeutics
FOLD
| $8.32M | ﹤0.01% |
1,055,861
+9,646
| +0.9% | +$68.7K |
|
|
ZBIO
1261
Zenas BioPharma
ZBIO
$1.89B
| $8.31M | ﹤0.01% |
374,298
-110,904
| -23% | -$1.81M |
|
|
GTLS
1262
DELISTED
Chart Industries
GTLS
| $8.31M | ﹤0.01% |
41,513
+2,907
| +8% | +$552K |
|
1263
Jefferies Financial Group
JEF
$12.8B
| $8.31M | ﹤0.01% |
126,977
+8,214
| +7% | +$501K |
|
1264
Mueller Water Products
MWA
$3.98B
| $8.27M | ﹤0.01% |
323,900
-9,614
| -3% | -$245K |
|
1265
Kodiak Sciences
KOD
$2.59B
| $8.22M | ﹤0.01% |
502,222
+463,661
| +1,202% | +$4M |
|
1266
RH
RH
$3.45B
| $8.16M | ﹤0.01% |
40,178
+1,413
| +4% | +$307K |
|
1267
Advanced Drainage Systems
WMS
$11.3B
| $8.14M | ﹤0.01% |
58,683
+4,051
| +7% | +$532K |
|
1268
OGE Energy
OGE
$9.81B
| $8.12M | ﹤0.01% |
175,478
+10,630
| +6% | +$476K |
|
|
SKYT
1269
DELISTED
SkyWater Technology
SKYT
| $8.12M | ﹤0.01% |
434,883
+422,327
| +3,364% | +$4.88M |
|
1270
Structure Therapeutics
GPCR
$3.82B
| $8.1M | ﹤0.01% |
289,393
-63,475
| -18% | -$1.26M |
|
1271
UFP Industries
UFPI
$4.99B
| $8.1M | ﹤0.01% |
86,657
-37,752
| -30% | -$3.81M |
|
|
SNV
1272
DELISTED
Synovus
SNV
| $8.09M | ﹤0.01% |
164,769
-245,418
| -60% | -$12.6M |
|
1273
Kaspi.kz JSC
KSPI
$18.8B
| $8.09M | ﹤0.01% |
98,998
+2,744
| +3% | +$240K |
|
1274
Fortune Brands Innovations
FBIN
$5.71B
| $8.04M | ﹤0.01% |
150,628
+8,030
| +6% | +$453K |
|
1275
BioMarin Pharmaceuticals
BMRN
$13.1B
| $8.02M | ﹤0.01% |
148,026
+10,100
| +7% | +$578K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.